a very strange fact about drug prices: They do not really exist
This drug is defying a rare form of leukemia — and it keeps getting pricier - The Washington Post
List prices are nothing more than a starting point for bargaining between drugmakers and the companies that provide prescription drug benefits. The cost for patients varies widely, influenced by discounts and rebates developed behind closed doors and applied in #secret.
To track how Gleevec became a multibillion-dollar drug, The Washington Post used the median amount paid by privately insured patients and their health plans before discounts and rebates, an analysis prepared by health services researcher Stacie Dusetzina of the University of North Carolina at Chapel Hill using data from Truven Health Analytics.